The DRIVE4COPD Campaign Screens 2 Million People!

September 29, 2011   |   
I Care 0 Cares

Today, the DRIVE4COPD campaign announced they have reached the impressive milestone of screening 2 million Americans to see if they are at risk for COPD.

Launched in February 2010, DRIVE4COPD is the nation's single largest awareness campaign for chronic obstructive pulmonary disease (COPD).

The COPD Foundation is proud to be a partner of this initiative and want to thank those members who have participated in this effort either by taking the screener or encouraging others to do the same. The COPD Foundation continues to support the initiatives and events organized by the DRIVE4COPD campaign, in its effort to spread education and awareness about COPD.

Of the 2 million people screened, more than 20 percent scored high enough to indicate potential risk for the disease. This shows that the campaign is reaching people who are in need of more information about COPD. Those individuals who took the screener were encouraged to share the results with their doctor or healthcare professional.

Together, the COPD Foundation’s efforts and those of campaigns like DRIVE4COPD are truly making an impact and changing the way COPD is viewed and addressed in America, but we are just getting started. COPD is the only leading cause of death in America that is on the rise and it kills more people each year than breast cancer and diabetes combined.

DRIVE4COPD is the nation's single largest awareness campaign for chronic obstructive pulmonary disease (COPD), the nation's fourth leading cause of death. Launched in February 2010 by Founding Sponsor Boehringer Ingelheim Pharmaceuticals, Inc., this landmark public health initiative is working to help people recognize the signs and symptoms of COPD, take action to see if they may be at risk and talk to their healthcare professional. DRIVE4COPD has been embraced by leading health, business, entertainment, and sports organizations with a common goal of driving fundamental change in COPD awareness in the United States.

Join Us on COPD360social

Sign In to Participate
Or register to become a member